Marwan Moussa, M.B.,Ch.B.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Catheter Ablation | 7 | 2022 | 2758 | 1.170 |
Why?
|
Antibiotics, Antineoplastic | 3 | 2016 | 675 | 1.100 |
Why?
|
Doxorubicin | 4 | 2016 | 2209 | 0.960 |
Why?
|
Evoked Potentials, Somatosensory | 1 | 2024 | 246 | 0.830 |
Why?
|
Cryosurgery | 2 | 2024 | 475 | 0.810 |
Why?
|
Evoked Potentials, Motor | 1 | 2024 | 461 | 0.750 |
Why?
|
Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2023 | 886 | 0.700 |
Why?
|
Neoplasms, Multiple Primary | 1 | 2023 | 586 | 0.670 |
Why?
|
Liposomes | 4 | 2023 | 777 | 0.640 |
Why?
|
Quercetin | 2 | 2016 | 97 | 0.640 |
Why?
|
Hyperaldosteronism | 4 | 2022 | 244 | 0.600 |
Why?
|
Rats, Inbred F344 | 7 | 2024 | 825 | 0.560 |
Why?
|
HSP70 Heat-Shock Proteins | 1 | 2016 | 397 | 0.460 |
Why?
|
Aldosterone | 4 | 2022 | 868 | 0.440 |
Why?
|
Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2014 | 621 | 0.360 |
Why?
|
Boronic Acids | 1 | 2014 | 914 | 0.350 |
Why?
|
Adrenal Glands | 3 | 2022 | 554 | 0.350 |
Why?
|
Nanoparticles | 3 | 2016 | 1943 | 0.350 |
Why?
|
Mammary Neoplasms, Experimental | 3 | 2016 | 507 | 0.320 |
Why?
|
Microvessels | 1 | 2013 | 572 | 0.320 |
Why?
|
Pyrazines | 1 | 2014 | 1199 | 0.310 |
Why?
|
Electroporation | 3 | 2014 | 255 | 0.300 |
Why?
|
Micelles | 3 | 2016 | 192 | 0.270 |
Why?
|
Chemotherapy, Adjuvant | 4 | 2016 | 3529 | 0.250 |
Why?
|
Up-Regulation | 1 | 2014 | 4122 | 0.250 |
Why?
|
Hepatocyte Growth Factor | 2 | 2022 | 267 | 0.210 |
Why?
|
Liver | 6 | 2016 | 7509 | 0.210 |
Why?
|
Granulocytes | 1 | 2023 | 551 | 0.190 |
Why?
|
Rats | 6 | 2024 | 23711 | 0.190 |
Why?
|
Splenic Artery | 1 | 2021 | 57 | 0.180 |
Why?
|
Myofibroblasts | 1 | 2022 | 207 | 0.180 |
Why?
|
Carcinoma, Hepatocellular | 2 | 2024 | 2299 | 0.180 |
Why?
|
Veins | 2 | 2021 | 765 | 0.170 |
Why?
|
Adrenocorticotropic Hormone | 1 | 2021 | 618 | 0.160 |
Why?
|
Polyethylene Glycols | 2 | 2016 | 1189 | 0.160 |
Why?
|
Cholangitis, Sclerosing | 1 | 2021 | 177 | 0.160 |
Why?
|
Renin | 1 | 2020 | 635 | 0.160 |
Why?
|
Liver Neoplasms | 2 | 2024 | 4319 | 0.140 |
Why?
|
Breast Neoplasms | 2 | 2014 | 21025 | 0.130 |
Why?
|
Kidney Neoplasms | 1 | 2013 | 4312 | 0.130 |
Why?
|
Forkhead Transcription Factors | 1 | 2023 | 1612 | 0.130 |
Why?
|
Radiology, Interventional | 1 | 2020 | 475 | 0.130 |
Why?
|
Animals | 14 | 2024 | 167963 | 0.130 |
Why?
|
Xenograft Model Antitumor Assays | 2 | 2014 | 3584 | 0.130 |
Why?
|
Vascular Endothelial Growth Factor A | 3 | 2022 | 3484 | 0.120 |
Why?
|
Sulfones | 1 | 2015 | 447 | 0.110 |
Why?
|
Disease Models, Animal | 4 | 2023 | 18137 | 0.100 |
Why?
|
Lymph Nodes | 1 | 2024 | 3486 | 0.100 |
Why?
|
Dendritic Cells | 1 | 2023 | 2725 | 0.100 |
Why?
|
Ablation Techniques | 1 | 2014 | 248 | 0.090 |
Why?
|
Embolization, Therapeutic | 1 | 2021 | 1413 | 0.090 |
Why?
|
Hypertension | 2 | 2021 | 8594 | 0.090 |
Why?
|
Particle Size | 1 | 2014 | 1644 | 0.090 |
Why?
|
Liver Transplantation | 1 | 2021 | 2325 | 0.080 |
Why?
|
Macrophages | 1 | 2023 | 5745 | 0.080 |
Why?
|
Ultrasonography, Interventional | 2 | 2013 | 1502 | 0.080 |
Why?
|
Cell Line, Tumor | 2 | 2016 | 16939 | 0.080 |
Why?
|
Hyperthermia, Induced | 1 | 2011 | 417 | 0.080 |
Why?
|
Time Factors | 2 | 2024 | 40165 | 0.070 |
Why?
|
Predictive Value of Tests | 1 | 2024 | 15289 | 0.070 |
Why?
|
Indoles | 1 | 2015 | 1829 | 0.070 |
Why?
|
Antineoplastic Agents | 3 | 2015 | 13630 | 0.070 |
Why?
|
Mice, Nude | 1 | 2013 | 3607 | 0.070 |
Why?
|
Female | 12 | 2024 | 391270 | 0.070 |
Why?
|
Spinal Cord Injuries | 1 | 2014 | 924 | 0.070 |
Why?
|
RNA, Small Interfering | 1 | 2015 | 3442 | 0.070 |
Why?
|
Lumbar Vertebrae | 1 | 2014 | 1868 | 0.060 |
Why?
|
Treatment Outcome | 4 | 2024 | 65017 | 0.060 |
Why?
|
Lactates | 1 | 2024 | 404 | 0.050 |
Why?
|
Pyruvic Acid | 1 | 2024 | 195 | 0.050 |
Why?
|
Phosphofructokinase-2 | 1 | 2022 | 32 | 0.050 |
Why?
|
Telemedicine | 1 | 2020 | 3018 | 0.050 |
Why?
|
Coronavirus Infections | 1 | 2020 | 3085 | 0.050 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 3205 | 0.050 |
Why?
|
Kidney | 2 | 2015 | 7064 | 0.050 |
Why?
|
Mice | 2 | 2022 | 81208 | 0.050 |
Why?
|
Prostatic Neoplasms | 1 | 2023 | 11345 | 0.040 |
Why?
|
Adrenalectomy | 1 | 2022 | 348 | 0.040 |
Why?
|
Pandemics | 1 | 2020 | 8624 | 0.040 |
Why?
|
Tomography, X-Ray Computed | 3 | 2023 | 20509 | 0.040 |
Why?
|
Swine | 3 | 2014 | 5899 | 0.040 |
Why?
|
Aged, 80 and over | 1 | 2024 | 58995 | 0.040 |
Why?
|
Blood | 1 | 2021 | 586 | 0.040 |
Why?
|
Postoperative Complications | 1 | 2021 | 15697 | 0.040 |
Why?
|
Glycolysis | 1 | 2022 | 828 | 0.040 |
Why?
|
Adenocarcinoma | 1 | 2015 | 6315 | 0.040 |
Why?
|
Lactic Acid | 1 | 2022 | 1134 | 0.040 |
Why?
|
Male | 7 | 2024 | 359744 | 0.040 |
Why?
|
Risk Factors | 1 | 2024 | 74359 | 0.040 |
Why?
|
Chromatography, Liquid | 1 | 2020 | 987 | 0.030 |
Why?
|
Middle Aged | 4 | 2024 | 220352 | 0.030 |
Why?
|
Retrospective Studies | 5 | 2023 | 80372 | 0.030 |
Why?
|
Humans | 10 | 2024 | 760621 | 0.030 |
Why?
|
Subcutaneous Tissue | 1 | 2015 | 132 | 0.030 |
Why?
|
Observer Variation | 1 | 2021 | 2601 | 0.030 |
Why?
|
Adult | 3 | 2024 | 219994 | 0.030 |
Why?
|
Syndrome | 1 | 2021 | 3280 | 0.030 |
Why?
|
Tandem Mass Spectrometry | 1 | 2020 | 1189 | 0.030 |
Why?
|
Radio Waves | 1 | 2015 | 250 | 0.030 |
Why?
|
Prostate-Specific Antigen | 1 | 2023 | 2529 | 0.030 |
Why?
|
Cell Proliferation | 2 | 2022 | 10446 | 0.030 |
Why?
|
Hydrocortisone | 1 | 2021 | 1803 | 0.030 |
Why?
|
Electric Conductivity | 1 | 2013 | 410 | 0.030 |
Why?
|
Feasibility Studies | 1 | 2023 | 5201 | 0.030 |
Why?
|
Aged | 1 | 2024 | 169152 | 0.020 |
Why?
|
Immunohistochemistry | 2 | 2015 | 11071 | 0.020 |
Why?
|
Electrodes | 1 | 2012 | 614 | 0.020 |
Why?
|
Heat-Shock Proteins | 1 | 2013 | 795 | 0.020 |
Why?
|
Hepatocytes | 1 | 2015 | 1229 | 0.020 |
Why?
|
Surgery, Computer-Assisted | 1 | 2014 | 1008 | 0.020 |
Why?
|
Sensitivity and Specificity | 1 | 2020 | 14660 | 0.020 |
Why?
|
Interleukin-6 | 1 | 2015 | 3215 | 0.020 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2023 | 9276 | 0.020 |
Why?
|
Blood Pressure | 1 | 2021 | 8525 | 0.020 |
Why?
|
Neovascularization, Pathologic | 1 | 2015 | 2640 | 0.020 |
Why?
|
Analysis of Variance | 1 | 2012 | 6238 | 0.010 |
Why?
|
Combined Modality Therapy | 1 | 2015 | 8552 | 0.010 |
Why?
|
Regression Analysis | 1 | 2012 | 6360 | 0.010 |
Why?
|
Neoplasms | 1 | 2011 | 22072 | 0.010 |
Why?
|
Reproducibility of Results | 1 | 2021 | 20080 | 0.010 |
Why?
|
Apoptosis | 1 | 2013 | 9501 | 0.010 |
Why?
|
Mice, Inbred C57BL | 1 | 2015 | 22023 | 0.010 |
Why?
|
Magnetic Resonance Imaging | 1 | 2024 | 36290 | 0.010 |
Why?
|
Young Adult | 1 | 2021 | 58741 | 0.010 |
Why?
|
Algorithms | 1 | 2013 | 13981 | 0.010 |
Why?
|
United States | 1 | 2020 | 72461 | 0.010 |
Why?
|